Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Suspended 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 2Head & Neck 1Breast 1

Conditions

Head and Neck Neoplasms 2102Squamous Cell Carcinoma of Head and Neck 1654Nasopharyngeal Carcinoma 517Thyroid Neoplasms 478Carcinoma, Non-Small-Cell Lung 437Breast Neoplasms 315Mouth Neoplasms 312Neoplasms 309Melanoma 299Oropharyngeal Neoplasms 285Colorectal Neoplasms 274Lung Neoplasms 247Carcinoma, Squamous Cell 239Neoplasm Metastasis 235Ovarian Neoplasms 228Uterine Cervical Neoplasms 204Stomach Neoplasms 195Salivary Gland Neoplasms 192Laryngeal Neoplasms 192Nasopharyngeal Neoplasms 189Carcinoma, Renal Cell 183Esophageal Neoplasms 179Pancreatic Neoplasms 176Prostatic Neoplasms 158Sarcoma 142Triple Negative Breast Neoplasms 136Urinary Bladder Neoplasms 135Recurrence 128Endometrial Neoplasms 124Hypopharyngeal Neoplasms 121

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Dihydropyrimidine Dehydrogenase Deficiency × Head & Neck × Clear all
NCT04541381 2026-05-07

The PhOCus Trial: Implementation of Pharmacogenomic Testing in Oncology Care

University of Chicago

Phase NA Suspended
860 enrolled
BreastGastrointestinalHead & Neck

Breast Neoplasms, Gastrointestinal Neoplasms, Head and Neck Neoplasms, Dihydropyrimidine Dehydrogenase Deficiency

Data powered by HemOnc (CC BY 4.0) Colophon âš¡